Monica Simeoni

Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents

Monica Simeoni, Paolo Magni, Cristiano Cammia et al. · Cancer Research · 2004 · 499 citations · Full text

Medicine, Oncology, Pharmacology +16

Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of <scp>RIPK</scp>1 inhibitor <scp>GSK</scp>2982772 in healthy volunteers

Kathleen Weisel, Nicola Scott, Debra Tompson et al. · Pharmacology Research & Perspectives · 2017 · 130 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Predicting the active doses in humans from animal studies: A novel approach in oncology

Maria Teresa Rocchetti, Monica Simeoni, Enrico Pesenti et al. · European Journal of Cancer · 2007 · 97 citations

Medicine, Oncology, Pharmacology +16

35th Annual Meeting of the European Association for the Study of Diabetes

Arne Melander, Jonny Olsson, Gunnar Lindberg et al. · Diabetologia · 1999 · 86 citations

Medicine, Endocrinology, Internal Medicine +11

Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study

Valerie J. Ludbrook, Kirsty Hicks, Kate Hanrott et al. · British Journal of Dermatology · 2016 · 85 citations

Medicine, Dermatology, Pharmacology +13